// App-Quantinova.ai

: A network-based drug-screening platform for Alzheimer’s disease by integrating mathematical modeling and pathological features of human brain organoids

Researchers

Presenter

  • Jong-Chan Park

Principal Investigators

  • So-Young Jang

  • Dongjoon Lee

  • Jeongha Lee

  • Uiryong Kang

  • Hongjun Chang

  • Haeng Jun Kim

  • Sun-Ho Han

  • Jinsoo Seo

  • Murim Choi

  • Dong Young Lee

  • Min Soo Byun

  • Dahyun Yi

  • Kwang-Hyun Cho

  • Inhee Mook-Jung

Medical Centers

  • Department of Neurodegenerative Disease, University College London

  • Neuropsychiatry, Seoul National University Hospital

  • KAIST

  • Seoul National University Bundang Hospital, Korea

  • Neuroscience Research Institute, Seoul National University College of Medicine

  • Chonnam National University Hospital

  • Stark Neurosciences Research Institute

  • Danish Dementia Research Centre

  • DGIST

  • Seoul National University,

  • Biomedical Research Center Seoul National University Hospital

  • Seoul National University College of Medicine, Seoul, Korea

  • Medical Research Center Seoul National University

  • Seoul National University, College of Medicine

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Cytochrome C

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A